Dudley Group NHS Foundation Trust, Rheumatology, Russells Hall Hospital, Dudley, West Midlands, UK.
Semin Arthritis Rheum. 2013 Apr;42(5):451-73. doi: 10.1016/j.semarthrit.2012.08.005. Epub 2013 Jan 29.
Variations in the degree of pain relief reported by patients with osteoarthritis following intra-articular corticosteroid injections are well recognized but the reasons for this are not widely understood and factors which might predict variations in response have not been subjected to systematic review. We set out to review systematically the literature relating to predictors of pain reduction following intra-articular corticosteroid injections in patients with knee and hip osteoarthritis.
Searches were performed using Medline, EMBASE, Web of Knowledge and MeSH search of Pubmed, the last search being performed in August 2012. Search terms included knee osteoarthritis, hip osteoarthritis, corticosteroid and related terms, and intra-articular injection. Papers were selected and reviewed by 2 reviewers. For inclusion, papers were required to describe studies in which patients with osteoarthritis of the knee or hip received intra-articular corticosteroid injection as an intervention, contain clearly defined outcome measures relating to pain and contain analysis relating to predictors of clinical response to treatment.
Twenty-one studies met criteria for inclusion from a total of 54 papers reviewed in full. Eight of these related to hip OA and 13 related to knee OA. No factors that were investigated as potential predictors of response, including radiographic grade and clinical or sonographic evidence of inflammation or synovial hypertrophy were supported by strong evidence. The review also identified that several plausible potential predictors had not been studied to date.
Previous research has not identified reliable predictors of response to IA corticosteroid injections, a widely practised intervention in knee and hip OA. Further studies are required if this question is to be answered.
关节内皮质类固醇注射治疗骨关节炎患者的疼痛缓解程度存在差异,这是众所周知的,但原因尚不清楚,也没有对预测反应变化的因素进行系统评价。我们旨在系统地回顾与膝关节和髋关节骨关节炎患者关节内皮质类固醇注射后疼痛减轻相关的预测因素的文献。
使用 Medline、EMBASE、Web of Knowledge 和 Pubmed 的 MeSH 搜索进行了搜索,最后一次搜索于 2012 年 8 月进行。搜索词包括膝骨关节炎、髋骨关节炎、皮质类固醇和相关术语以及关节内注射。由 2 名评审员选择和审查论文。纳入标准为:描述膝关节或髋关节骨关节炎患者接受关节内皮质类固醇注射作为干预措施的研究;包含与疼痛相关的明确界定的结局测量;并包含与治疗临床反应预测因素相关的分析。
从总共 54 篇全文审查的论文中,有 21 篇符合纳入标准。其中 8 篇与髋 OA 相关,13 篇与膝 OA 相关。没有证据支持将包括放射学分级和炎症或滑膜肥大的临床或超声证据在内的被认为是潜在反应预测因素的因素作为可靠的预测因素。该综述还确定,迄今为止,一些合理的潜在预测因素尚未得到研究。
以前的研究尚未确定关节内皮质类固醇注射反应的可靠预测因素,这是一种在膝关节和髋关节骨关节炎中广泛应用的干预措施。如果要回答这个问题,还需要进一步的研究。